In conclusion, CD39+CD103+ TRM cells and CD8+ TIL in endometrial cancer are responsive to reactivation and produce both classical and non-classical cytokines that can influence both T cell and B cell function. This evidence concerns the gene ENTPD1 and endometrial cancer.